Status:
COMPLETED
Test Semiquantitative Prostate Specific Antigen (PSA)
Lead Sponsor:
Institut Curie
Conditions:
Prostate Cancer
Prostatic Neoplasms
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The aim of the study is to compare the diagnostic performances of a simple and rapid PSA assay on whole blood to the standard plasma PSA assay.
Detailed Description
Screening and surveillance of prostate cancer typically involves sensitive laboratory techniques for the quantification of plasma prostate specific antigen (PSA). In this study, we determine the sensi...
Eligibility Criteria
Inclusion
- Patients followed for prostate cancer or symptomatic benign prostatic disease, and for who a PSA assay is indicated.
- Patients must have given informed consent.
Exclusion
- Patients followed for a disease other than prostatic.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT00853710
Start Date
March 1 2009
End Date
July 1 2009
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Rene Huguenin
Saint-Cloud, France, 92210